Stocks VIOT Financial statements
Financial statementsViomi Technology Co., Ltd financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Viomi Technology Co., Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 373 | 668 | 893 | 832 | 469 | 351 | 290 | 347 |
| Cost of revenue | 268 | 512 | 727 | 644 | 362 | 271 | 215 | 259 |
| Gross profit | 104 | 155 | 166 | 188 | 107 | 80.2 | 75.2 | 87.9 |
| Research and development | 18.1 | 29.4 | 40.7 | 48.9 | 43.5 | 31.4 | 19.6 | 23.7 |
| Selling and marketing | 55.2 | 76 | 91.5 | 118 | 89.2 | 56.6 | 28.9 | 39.7 |
| General and administrative | 19.7 | 10.5 | 10.6 | 15.3 | 17.6 | 11.5 | 9.7 | 12.3 |
| Operating expenses | 93 | 116 | 143 | 182 | 150 | 99.5 | 58.2 | 75.7 |
| Operating income | 21.4 | 18.4 | ||||||
| Other non-operating income | -0.07 | |||||||
| Pre-tax income | 13 | 48.7 | 33.4 | 14.8 | -38.3 | -12.3 | 22.1 | 22.1 |
| Income tax | 3.5 | 6.49 | 6.64 | 0.9 | 2.64 | 0.24 | 2.32 | 1.81 |
| Income from continuing operations | 11.7 | 44.7 | 28.2 | 10.1 | -40.2 | -16.8 | 19.8 | 20.3 |
| Net income to minority interests | -0 | 0.24 | 0.17 | 0.05 | -1.03 | -0.66 | -0.15 | 0.04 |
| Net income | 9.51 | 42 | 26.6 | 13.9 | -39.9 | -11.9 | 8.69 | 20.3 |
| EBITDA | 25.4 | 24.4 | ||||||
| EPS, basic | 0.10 | 0.20 | 0.13 | 0.07 | -0.19 | -0.06 | 0.04 | 0.10 |
| EPS, diluted | 0.09 | 0.19 | 0.12 | 0.06 | -0.19 | -0.06 | 0.04 | 0.10 |
| Shares, basic (weighted) | 71.8 | 208 | 209 | 210 | 208 | 206 | 205 | 204 |
| Shares, diluted (weighted) | 79.6 | 216 | 216 | 221 | 210 | 208 | 207 | 211 |
Balance sheet
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 137 | 140 | 77.3 | 92.1 | 107 | 69.3 | 141 | 115 |
| Short-term investments | 24.6 | 45.4 | 107 | 130 | 28.6 | 9.91 | 9.93 | 11.8 |
| Receivables | 16.2 | 45.4 | 65.5 | 47.4 | 35 | |||
| Inventory | 33.7 | 60 | 67.3 | 90.4 | 72.8 | 62.3 | 15.4 | 18.1 |
| Other current assets | 6.82 | 8.95 | 13.4 | 24.5 | 26.6 | 26.3 | 9.78 | 22.5 |
| Total current assets | 277 | 418 | 449 | 462 | 362 | 322 | 297 | 280 |
| Property, plant and equipment | 1.64 | 9.67 | 11.1 | 22.9 | 34.3 | 48.3 | 43.2 | 43.7 |
| Lease right-of-use assets | 2.84 | 3.15 | 2.89 | 2.12 | 0.7 | 0.46 | 0.24 | |
| Intangible assets | 0.03 | 0.63 | 1.18 | 1.91 | 1.98 | 1.54 | 1.17 | 0.89 |
| Long-term investments | 3.36 | 1.04 | 1.85 | |||||
| Total assets | 280 | 434 | 487 | 514 | 418 | 388 | 354 | 342 |
| Accounts payable | 79.8 | 150 | 153 | 168 | 122 | 93.9 | 106 | 74.1 |
| Deferred revenue | 12.6 | 14.8 | 17.3 | 15.6 | 17.2 | 18.5 | 1.58 | 1.45 |
| Short-term debt | 13.8 | 2.93 | 3.95 | 4.01 | 3.58 | |||
| Total current liabilities | 124 | 235 | 250 | 250 | 192 | 178 | 143 | 108 |
| Long-term debt | 2.53 | 16.6 | 18.1 | 10.4 | 7.39 | |||
| Lease liabilities | 1.92 | 1.79 | 1.19 | 0.99 | 0.38 | 0.24 | 0.06 | |
| Total liabilities | 124 | 237 | 253 | 255 | 211 | 199 | 156 | 123 |
| Total debt | 2.53 | 19.5 | 22.1 | 14.4 | 11 | |||
| Paid-in capital | 174 | 171 | 196 | 210 | 197 | 191 | 188 | |
| Retained earnings | -13.9 | 28.1 | 55.6 | 70.6 | 25.3 | 12.6 | 21 | |
| Treasury stock | -8.37 | -10.5 | -10.8 | -11.4 | -11.7 | |||
| Other comprehensive income | -4.33 | -2.75 | -9.1 | -11.5 | -3.53 | -2.02 | 0.31 | |
| Shareholders' equity | 155 | 197 | 234 | 259 | 208 | 190 | 198 | 218 |
| Minority interests | 0.44 | 0.81 | 0.5 | 0.55 | -0.52 | -0.6 | 0.73 | 0.8 |
| Total equity | 156 | 197 | 235 | 259 | 207 | 189 | 199 | 219 |
| Total liabilities and equity | 280 | 434 | 487 | 514 | 418 | 388 | 354 | 342 |
Cash flow statement
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | 9.5 | 42.2 | 26.7 | 13.9 | -41 | -12.6 | 8.54 | 20.3 |
| Depreciation and amortization | 0.33 | 3.39 | 8.32 | 11.3 | 12.8 | 9.14 | 3.97 | 6.02 |
| Stock-based compensation | 17 | 6.2 | 11.1 | 7.44 | 2.84 | 0.01 | 2.25 | 2.01 |
| Deferred income tax | -0.32 | -1.01 | -0.23 | -3.31 | 3.28 | 0.24 | -0.65 | 0.2 |
| Change in receivables | -15.6 | |||||||
| Change in inventory | -26.5 | -29 | -6.73 | -22.8 | 5.98 | 4.08 | 7.54 | -2.14 |
| Cash from operations | 32.3 | 35.3 | 28.4 | 48.5 | -41.2 | -14.5 | 98.1 | 22.1 |
| Capital expenditures | -1.96 | -8.06 | -7.28 | -15.6 | -28.4 | -15.5 | -3.92 | -5.89 |
| Purchases of investments | -34.7 | -117 | -499 | -282 | -50.5 | -15.6 | -12 | -30.8 |
| Cash from investing | -22.1 | -38.6 | -66.4 | -41.6 | 45.6 | -28 | -22.6 | -33.3 |
| Debt issued | 8.02 | 5.88 | ||||||
| Debt repaid | -8.22 | -11.4 | ||||||
| Stock issued | 0.16 | 1.01 | 2.03 | 0.43 | 0 | 0.02 | 0.05 | |
| Share buybacks | -8.37 | -1.89 | -1.17 | -0.91 | -0.59 | -2.53 | ||
| Dividends paid | -6.69 | 0 | ||||||
| Cash from financing | 88 | 6.97 | -22.4 | 2.69 | 16.5 | 16.3 | -4.75 | -15.1 |
| Exchange rate effect | 2.11 | 1.16 | -5.22 | -1.99 | ||||
| Net change in cash | 100 | 4.76 | -65.6 | 7.54 | 27.6 | -24.9 | 72.8 | -28.1 |
| Free cash flow | 30.4 | 27.2 | 21.1 | 32.9 | -69.6 | -30.1 | 94.2 | 16.2 |
| Interest paid | 0.11 | 0.14 | 0.01 | 0.79 | 0.85 | |||
| Income taxes paid | 4.02 | 4.01 | 4.2 | 5.41 | 3.31 | 0.03 | 0.31 | 2.95 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 25.3% | Gross profit / revenue. |
| Operating margin | 5.3% | Operating income / revenue. |
| EBITDA margin | 7.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 6.4% | Pre-tax income / revenue. |
| Net margin | 5.8% | Net income / revenue. |
| FCF margin | 4.7% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 6.4% | Cash from operations / revenue. |
| Effective tax rate | 8.2% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 9.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 5.8% | Net income / average total assets. |
| Return on invested capital (ROIC) | 18.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 6.8% | Research and development expense / revenue. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.7% | Capital expenditures / revenue. |
| D&A / revenue | 1.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 19.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -9.5% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -17.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 17.0% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -6.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -11.9% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -14.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -3.9% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | 133.2% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 5y | -5.3% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 150.0% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 5y | -3.6% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -77.5% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 5y | -4.9% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -82.8% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | -5.1% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 10.3% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 1.7% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -1.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -3.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -6.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -6.8% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 2.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.1% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -0.4% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.60x | Current assets / current liabilities. |
| Quick ratio | 1.18x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.18x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.05x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 3.2% | Total debt / total assets. |
| Liabilities / assets | 35.9% | Total liabilities / total assets. |
| Net debt | -$116.2M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | -4.76x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $172.6M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $217.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.00x | Revenue / average total assets. |
| Fixed asset turnover | 7.99x | Revenue / average property, plant and equipment. |
| Inventory turnover | 15.5x | Cost of revenue / average inventory. |
| Days inventory | 24 days | 365 x average inventory / cost of revenue. |
| Days payables | 127 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 80.1% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 26.6% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.10 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.10 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $1.65 | Revenue / diluted weighted shares. |
| FCF per share | $0.08 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.10 | Cash from operations / diluted weighted shares. |
| Book value per share | $1.04 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.03 | Tangible book value / shares outstanding. |
| Cash per share | $0.60 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 15.6% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $84.3M | Share price x shares outstanding. |
| Enterprise value | -$31.9M | Market cap + total debt - cash - short-term investments. |
| P/E | 4.16x | Market cap / net income. Only when net income is positive. |
| P/S | 0.24x | Market cap / revenue. |
| P/B | 0.39x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.39x | Market cap / tangible book value, when positive. |
| P/FCF | 5.20x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 3.81x | Market cap / cash from operations, when positive. |
| FCF yield | 19.2% | Free cash flow / market cap. |
| Earnings yield | 24.0% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 3.0% | (Dividends paid + share buybacks) / market cap. |
What was Viomi Technology Co., Ltd's revenue in fiscal 2025?
Viomi Technology Co., Ltd reported revenue of $347.2M for fiscal 2025, 19.6% higher than the year before.
Was Viomi Technology Co., Ltd profitable in fiscal 2025?
Yes. Net income was $20.3M, a net margin of 5.8%.
How much free cash flow did Viomi Technology Co., Ltd generate in fiscal 2025?
Cash from operations of $22.1M minus capital expenditures of $5.9M left free cash flow of $16.2M.